Literature DB >> 9019368

Do we have optimal screening limits in Sweden for vision testing at the age of 4 years?

A L Hård1, P Williams, J Sjöstrand.   

Abstract

The purpose of this study was to evaluate the Swedish screening criteria for referral of children to ophthalmic care after visual acuity testing at the age of 4 years. The screening limit has generally been 0.8. To what extent do children with 0.65 in each eye (0.65/0.65) or 0.65 in one and 0.8 in the other (0.65/0.8) at the age of 4 years have visual defects needing early treatment? Sixty-three children who had failed screening underwent orthoptic and ophthalmologic evaluation. Twenty-four patients (38%) saw 0.65/0.65 or 0.65/0.8 and were studied further. None of them had manifest strabismus. Refractive errors were minor except in 2 patients who had significant hyperopia. Twenty-two of these 24 patients returned for reevaluation at the age of five years and that time 18 of them saw 0.8 or more without treatment. Our findings suggest that children with visual acuity of no less than 0.65 and no more than one line's difference between the eyes at 4 years of age seldom have visual defects needing treatment.

Entities:  

Mesh:

Year:  1995        PMID: 9019368     DOI: 10.1111/j.1600-0420.1995.tb00320.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  4 in total

1.  Preschool hearing, speech, language, and vision screening.

Authors:  J Bamford; A Davis; J Boyle; J Law; S Chapman; S S Brown; T A Sheldon
Journal:  Qual Health Care       Date:  1998-12

2.  Natural history of amblyopia untreated owing to lack of compliance.

Authors:  K Simons; M Preslan
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

3.  Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening.

Authors:  M P Clarke; C M Wright; S Hrisos; J D Anderson; J Henderson; S R Richardson
Journal:  BMJ       Date:  2003-11-29

Review 4.  Effectiveness of screening preschool children for amblyopia: a systematic review.

Authors:  Christine Schmucker; Robert Grosselfinger; Rob Riemsma; Gerd Antes; Stefan Lange; Wolf Lagrèze; Jos Kleijnen
Journal:  BMC Ophthalmol       Date:  2009-07-16       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.